Gabriele Fischer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gabriele Fischer has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Annemarie Unger
Clinical Division of Social Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, 1090 Vienna, Austria
6 shared publications - Reinhold Jagsch
Faculty of Psychology, University of Vienna, Liebiggasse 5, 1010 Vienna, Austria
5 shared publications Annemarie Unger
Medical University of Vienna, Department of Psychiatry and Psychotherapy, Waehringer Guertel 18-20, 1090 Vienna, Austria
4 shared publicationsBernadette Winklbaur
Medical University of Vienna, Department of Psychiatry and Psychotherapy , Vienna, Austria
4 shared publicationsNina Ebner
Department of Psychiatry and Psychotherapy, Medical University Vienna, Waehringer Guertel 18-20, Vienna, Austria
4 shared publicationsKenneth Thau
Department of Psychiatry and Psychotherapy, Medical University Vienna, Waehringer Guertel 18‐20, Vienna, Austria and
3 shared publications
Latest Publications
- Open Access
- 1 April 2018
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 185, 40-49
Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes
- 1 April 2018
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 185, 40-49
Open AccessPrenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes
- 1 January 2015
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 146, e230
Effects of maternal opioid maintenance therapy on neonatal outcomes: Methadone vs. buprenorphine
- 1 January 2015
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 146, e230
Effects of maternal opioid maintenance therapy on neonatal outcomes: Methadone vs. buprenorphine
- 2 September 2014
- Published by Oxford University Press (OUP)
Drug Dependence During Pregnancy and the Postpartum Period
The chaotic lives of women who are drug dependent and their frequent lack of consistent prenatal care put them at risk for many medical problems during pregnancy. Illicit drug use during pregnancy also places women at increased risk for obstetrical complications. The complexity of medical problems in the pregnant drug abuser is complicated by the attendant psychosocial problems and psychiatric comorbidities seen in this population. Psychiatric diagnoses, treatment, and patient compliance are often hindered when the main focus of attention is on drug-related problems. The stigma associated with maternal drug use and difficult life circumstances are additional burdens to successful treatment entry and adherence for women. The basis for stabilizing most opioid-dependent pregnant women is agonist maintenance therapy in the context of comprehensive services, and the treatment of psychiatric comorbidities is a key component in optimizing pregnancy and child outcomes.
- 2 September 2014
- Published by Oxford University Press (OUP)
Drug Dependence During Pregnancy and the Postpartum Period
The chaotic lives of women who are drug dependent and their frequent lack of consistent prenatal care put them at risk for many medical problems during pregnancy. Illicit drug use during pregnancy also places women at increased risk for obstetrical complications. The complexity of medical problems in the pregnant drug abuser is complicated by the attendant psychosocial problems and psychiatric comorbidities seen in this population. Psychiatric diagnoses, treatment, and patient compliance are often hindered when the main focus of attention is on drug-related problems. The stigma associated with maternal drug use and difficult life circumstances are additional burdens to successful treatment entry and adherence for women. The basis for stabilizing most opioid-dependent pregnant women is agonist maintenance therapy in the context of comprehensive services, and the treatment of psychiatric comorbidities is a key component in optimizing pregnancy and child outcomes.
- 11 June 2014
- Published by Springer Nature
- p. 1-8
Opioid Dependence and Its Treatment
- 9 May 2014
- Published by Springer Nature
- p. 169-195
Management of Substance Abuse in Pregnancy: Maternal and Neonatal Aspects
- 9 May 2014
- Published by Springer Nature
- p. 169-195
Management of Substance Abuse in Pregnancy: Maternal and Neonatal Aspects
- Open Access
- 21 June 2012
- Published by S. Karger AG in Gerontology
- Vol. 58 (6) , 540-544
Age-Related Aspects of Addiction
Research has shown that substance use, abuse and addiction are not limited to a specific age group. Problems related to substance addiction are an important cause of morbidity in the population aged 65 years and above, especially the abuse of prescription drugs and legal substances. A lack of evidence-based studies and tailored treatment options for the aging population is evident. Appropriate and effective health care is an important goal to improve the health-related quality of life of elderly people. Research in the increasingly aging population needs to include an age- and gender-sensitive approach.
- 21 June 2012
- Published by S. Karger AG in Gerontology
- Vol. 58 (6) , 540-544
Open AccessAge-Related Aspects of Addiction
Research has shown that substance use, abuse and addiction are not limited to a specific age group. Problems related to substance addiction are an important cause of morbidity in the population aged 65 years and above, especially the abuse of prescription drugs and legal substances. A lack of evidence-based studies and tailored treatment options for the aging population is evident. Appropriate and effective health care is an important goal to improve the health-related quality of life of elderly people. Research in the increasingly aging population needs to include an age- and gender-sensitive approach.
- 6 March 2012
- Published by Wiley in European journal of pain
- Vol. 16 (4) , 574-584
Peripartum pain management in opioid dependent women
Increased pain sensitivity and the development of opioid tolerance complicate the treatment of pain experiencedby opioid maintained pregnantwomenduring delivery and the perinatal period. Theaim of the present study was to investigate differences in pain management of opioid maintained compared to nondependent pregnant women during delivery and the postpartum period. 40 deliveries of 37 opioid dependent women enrolled in a double‐blind, double‐dummy randomized controlled trial (RCT) examining the safety and efficacy of methadone (mean dose at the time of delivery = 63.89 mg) and buprenorphine (mean dose at the time of delivery = 14.05 mg) during pregnancy were analyzed and participants were matched to a non‐dependent comparison group of 80 pregnant women. Differences in pain management (opioid and non‐opioid analgesic medication) during delivery and perinatal period were analyzed. Following cesarean delivery opioid maintained women received significantly less opioid analgesics (day of delivery p = 0.038; day 1: p = 0.02), NSAIDs were administered more frequently to opioid dependent patients than to the comparison group during cesarean section and on the third day postpartum. Significantly higher nicotine consumption in the group of opioid dependentwomenhad a strong influence onthe retrieved results, and might be considered as an independent factor of altered pain experience. Differences in pain treatment became evident when comparing opioid maintained women to healthy controls. These differences might be based on psychosocial consequences of opioid addiction along with the lack of an interdisciplinary consensus on pain treatment protocols for opioid dependent patients.
- 6 March 2012
- Published by Wiley in European journal of pain
- Vol. 16 (4) , 574-584
Peripartum pain management in opioid dependent women
Increased pain sensitivity and the development of opioid tolerance complicate the treatment of pain experiencedby opioid maintained pregnantwomenduring delivery and the perinatal period. Theaim of the present study was to investigate differences in pain management of opioid maintained compared to nondependent pregnant women during delivery and the postpartum period. 40 deliveries of 37 opioid dependent women enrolled in a double‐blind, double‐dummy randomized controlled trial (RCT) examining the safety and efficacy of methadone (mean dose at the time of delivery = 63.89 mg) and buprenorphine (mean dose at the time of delivery = 14.05 mg) during pregnancy were analyzed and participants were matched to a non‐dependent comparison group of 80 pregnant women. Differences in pain management (opioid and non‐opioid analgesic medication) during delivery and perinatal period were analyzed. Following cesarean delivery opioid maintained women received significantly less opioid analgesics (day of delivery p = 0.038; day 1: p = 0.02), NSAIDs were administered more frequently to opioid dependent patients than to the comparison group during cesarean section and on the third day postpartum. Significantly higher nicotine consumption in the group of opioid dependentwomenhad a strong influence onthe retrieved results, and might be considered as an independent factor of altered pain experience. Differences in pain treatment became evident when comparing opioid maintained women to healthy controls. These differences might be based on psychosocial consequences of opioid addiction along with the lack of an interdisciplinary consensus on pain treatment protocols for opioid dependent patients.
- Open Access
- 7 February 2012
- Published by Wiley in Obstetrics and Gynecology International
- Vol. 2012, 1-6
Opioid Dependent and Pregnant: What Are the Best Options for Mothers and Neonates?
Pregnancy in opioid-dependent women is a major public health issue. Women who are afflicted by opioid addiction are a highly vulnerable group of patients frequently becoming pregnant unplanned and at risk of adverse pregnancy outcomes and peri-natal complications. Opioid agonist maintenance treatment is the best option for the majority of women. Ideally, early and closely monitored treatment in an interdisciplinary team approach including social workers, nurses, psychologists, psychiatrists, gynecologists, anesthesiologists, and pediatricians should be provided. The treatment of comorbid psychiatric conditions, the resolution of financial, legal, and housing issues, and the psychosocial support provided have a significant effect on optimizing pregnancy outcomes. This paper aims to update health professionals in the field of gynecology and obstetrics on the latest optimal treatment approaches for mothers suffering from opioid dependence and their neonates.
- 7 February 2012
- Published by Wiley in Obstetrics and Gynecology International
- Vol. 2012, 1-6
Open AccessOpioid Dependent and Pregnant: What Are the Best Options for Mothers and Neonates?
Pregnancy in opioid-dependent women is a major public health issue. Women who are afflicted by opioid addiction are a highly vulnerable group of patients frequently becoming pregnant unplanned and at risk of adverse pregnancy outcomes and peri-natal complications. Opioid agonist maintenance treatment is the best option for the majority of women. Ideally, early and closely monitored treatment in an interdisciplinary team approach including social workers, nurses, psychologists, psychiatrists, gynecologists, anesthesiologists, and pediatricians should be provided. The treatment of comorbid psychiatric conditions, the resolution of financial, legal, and housing issues, and the psychosocial support provided have a significant effect on optimizing pregnancy outcomes. This paper aims to update health professionals in the field of gynecology and obstetrics on the latest optimal treatment approaches for mothers suffering from opioid dependence and their neonates.